MDCell InnovationLab Logo

Helmholtz Innovation Lab

MDC researchers are translating a new cancer therapy involving reprogrammed immune cells from the laboratory scale to the clinic, and are cooperating with industry partners to achieve this. The Helmholtz Association is supporting the transfer process by setting up a Helmholtz Innovation Lab at the MDC.

Whether repairing faulty genes or introducing characteristics by delivering new genes into cells, gene therapy holds great potential for personalized medicine. However, safe, efficient and cost-effective therapies of this kind are currently few and far between for clinical use. 

Group Picture of the Innovation Lab Team, Jan 2018